Consumers Suffering from Bextra and Vioxx Side Effects Have Hope for Justice as the FDA Puts Pressure on Drug Companies Producing Certain Pain Medications

Consumers Suffering from Bextra and Vioxx Side Effects Have Hope for Justice as the FDA Puts Pressure on Drug Companies Producing Certain Pain Med...

 

Consumers Suffering from Bextra and Vioxx Side Effects Have Hope for Justice as the FDA Puts Pressure on Drug Companies Producing Certain Pain Medications











New York City, New York (PRWEB) October 31, 2005

Since the recall of Bextra, Pfizer has been the defendant in a number of class action lawsuits in both state and federal courts facing allegations of false advertising, securities fraud, and personal injury related to both Bextra and Celebrex. To seek help, consumers submit their personal grievances with these drugs to LawyersandSettlements.com in hopes of legal representation and compensation.

Since Bextra’s launch in 2001, it has been prescribed to millions of consumers throughout the U.S., Canada, and the European Union as a pain reliever for those suffering from Osteoarthritis, Rheumatoid Arthritis, and severe menstrual cramps (Primary Dysmenorrhea). After an analysis of available information and clinical study results, the FDA concluded that the risks of cardiovascular damage and fatal skin diseases outweighed benefits and asked Pfizer to remove the drug from the U.S. market. Canada and the European Union quickly followed.

After further analysis, the FDA issued a warning label change for all Cox-2 inhibitor drugs and NSAIDS (Bextra, Celebrex, Vioxx, Aspirin, ibuprofen, Aleve, and others) to note an increased risk of cardiovascular (CV) problems and potential life-threatening gastrointestinal (GI) bleeding. To date consumers have linked Bextra with heart attacks/strokes, stomach ulcers, deadly skin diseases Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis, anaphylactic shock, and liver damage.

Consumers that have been affected by Bextra and related Cox-2 inhibitor drugs are confident that they will receive justice and compensation as they look to a recent precedent-setting Vioxx lawsuit in which a Texas jury awarded a multi-million dollar settlement to the plaintiff (Case No. 19961- BH02).

LawyersandSettlements.com promotes free case evaluations for those affected by Bextra; to join a Bextra class action lawsuit, submit your case for free legal evaluation by visiting: https://www.lawyersandsettlements.com/case/bextra

About Online Legal Marketing (OLM) and www.lawyersandsettlements.com:

LawyersandSettlements.com offers a comprehensive website with up-to-date legal news, class action lawsuits, personal injury cases, settlement details, product recalls, and more. Consumers can receive free case evaluations. Justice for Everyone.

Visit us at:

http://www.lawyersandsettlements.com/

Contact us at:

604-608-3435

###




















VocusВ©Copyright 1997-2010, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.







Should I?

 

Should I?











(PRWEB) August 22, 2002

A recent study suggests that regular, moderate coffee drinking may protect smokers from bladder cancer. In the study, smokers who didn’t drink coffee were seven times more likely to develop bladder cancer.

It is estimated that 50% of the cases of bladder cancer in men and 30% in women are due to smoking.

Dr. Johnson, head of intestinal physiology and cellular matabolism at the Institute of Food Research, says that coffee drinking has similar protective effects as eating cruciferous vegetables such as broccoli and Brussels sprouts, but that cruciferous vegetables may be more effective in preventing bladder cancer.

The risk for kidney stone formation decreased by 10% per 8-oz cup of coffee consumed. This is reported in ‘Beverage use and risk for kidney stones in women’ by Curhan, GC; Willett, WC; Speiger, FE; and Stampfer, MJ.

Dr. Edward Giovannucci included five case studies in his report that showed increased coffee consumption to be associated with a reduced risk of large bowel cancer.

In all studies combined, coffee drinkers had a 24%

lower risk of colorectal cancer relative to infrequent or nondrinkers.

‘The risk of colorectal adenoma, a cancer recursor, was found to be a precursor in approximately half the risk in those invividuals with frequest coffee consumption versus those with infrequent consumption.’ [Dr. Edward Giovannucci].

Mayo Clinic research studies have shown that heavy coffee drinkers [four or more cups daily] seem to develop Parkinson’s disease less often. Similar results were shown in a study done by neurologists Demetrius Margavore and Walter Rocca; Honolulu Heart Study, 2000; and one done by Harvard Medical School.

Researchers say the question is ‘do heavy coffee drinkers share a personality type that renders them less likely to develop Parkinson’s disease?’. Dr. Margavore said a direct effect of drinking coffee remains unproven.

And last, but not least, one cup of coffee has the anti-oxidant properties of two glasses of orange juice.

Two 8-oz cups per day is considered an average or moderate amount. Five 8-oz cups per day is excessive and can cause health problems.

Coffee drinking is contra-indicated for pregnant women, people with coronary disease, those with peptic ulcers, or high blood pressure.

When you are taking caffeine, it is especially important that your health care professional know if you are taking any of the following:

AmantadineВ В В В or

AmphetaminesВ В В В or

Appetite suppressantsВ В В В or

BupropionВ В В В or

ChlophedianolВ В В В or

Cocaine or

FluoxetineВ В В В or

Medicine for asthma or other breathing problems or

Medicine for colds, sinus problems, hay fever or other allergies

or

MethylphenidateВ В В В or

NabiloneВ В В В or

Other medicines or beverages containing caffeine or

ParoxetineВ В В В or

Sertraline (e.g., Zoloft)-Using these medicines with caffeine may

increase the CNS-stimulant effects, such as nervousness,

irritability, or trouble in sleeping, or possibly cause convulsions

(seizures} or changes in the rhythm of your heart.

Monoamine oxidase (MAO) inhibitors -Taking large amounts of caffeine while you are taking, or within two weeks of taking MAO inhibitors may cause extremely high blood pressure or dangerous changes in the rhythm of your heart. Taking small amount of caffeine may cause mild high blood pressure and fast heartbeat.

Other medical problems:

The presence of other medical problems may affect

the use of caffeine. Make sure you tell your doctor if you have any other medical problems,

other medical problems, especially:

Agoraphobia or

Anxiety or

Convulsions {in newborn babies} or

Heart disease, severe or

High blood pressure or

Panic attacks or

Trouble in sleeping – Caffeine may make the condition worse

Liver disease – Higher blood levels of caffeine may result, increasing the chance of side effects.

The above information should not be used for diagnosis or treatment of any medical condition. A

licensed physician should be consulted for

diagnosis and treatment of any and all medical conditions. There is no warranty that the information is free from errors and omissions or that it meets any particular standard.

Resources:

Ann. Intern. Med. 1998, Apr 1; 128 [7] i534.40

Dr. Gonzalo Lopez-Abente, Carlos 111, Health Institute of Madrid, Spain.

Dr. Ian Johnson, Institute of Food Research.

Dr. Edward Giovannucci, Journal of Epidemiology, 147 : 1043-1052

.

Mayo Clinic, Nov 14 2000.

MDX [Medical Data Exchange] Health Digest.

Nutrition Research Newsletter; Issue: July-Aug: 1998.

Dr. Demetrius Margavore, Neurologist.

Dr. Walter Rocca, Neurologist.

Reported in ‘Beverage Use & Risk For Kidney Stones In Women’ by Curhan,

GC; Willett, WC; Speiger, FE; and Stampfer, MJ.

*****************************************************************************************

By Margot B/Writer, Editor, Researcher, Web Developer

mailto:margotb@wonderport.com

Web: http://margot.bravenet.com



















VocusВ©Copyright 1997-2010, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.







Buy VIAGRA http://viagra.medical-dictionary-search-engines.com/ to correct ED – Erectile Dysfunction.

 

Buy VIAGRA http://viagra.medical-dictionary-search-engines.com/ to correct ED – Erectile Dysfunction.











(PRWEB) June 3, 2004

Buy VIAGRA http://viagra.medical-dictionary-search-engines.com/ to correct ED – Erectile Dysfunction. The good news is that male erectile dysfunction can often be treated by Viagra.

ED can be a physical problem. Normally, when a man is sexually excited, his penis fills with more blood than usual and it becomes erect or hard. When a man has ED, his penis does not fill with enough blood to get erect or hard. Or it may not stay erect long enough to complete sex.

Many men have this health problem. In fact, about 30 million men in the United States have ED to some degree. And studies show that about half of the men between the ages of 40 and 70 have ED to some degree.

There are many reasons why a man may develop ED. Despite the common myth, ED is not simply a result of aging. It is more likely to be caused by an underlying health problem.

Some causes of ED can be high blood pressure, high cholesterol, diabetes, heart disease, or depression.

Stress, injuries, operations, certain medicines, smoking, drug abuse, or too much alcohol may also cause ED.

VIAGRA is a prescription drug used to treat erection difficulties, such as erectile dysfunction (ED). Since it first became available in 1998, the prescription drug VIAGRA has helped about 16 million men around the world improve their sex lives. Amazingly, 9 tablets are dispensed every second worldwide. And no other therapy or prescription drug for erectile dysfunction has been studied as much or has the same amount of real-world experience as VIAGRA since its launch. It’s no wonder more than 600,000 doctors have chosen the prescription drug VIAGRA for their patients with ED.

Fact is, when taken correctly, VIAGRA works for most men. Studies show that it works for up to 4 out of 5 men (versus 1 out of 4 on sugar pill). VIAGRA improves erections in most men no matter how long they have had ED, what caused it, how often they have it, or how old they are. And VIAGRA has been proven to work in clinical studies of thousands of men.

VIAGRA is a prescription drug that works by increasing blood flow to the penis. It is not a hormone or an aphrodisiac. Once you take it, VIAGRA can work in as quickly as 30 minutes. VIAGRA works for 4 hours so you can set your own pace. And, in most patients, VIAGRA can be taken as often as once a day.

To buy VIAGRA please visit http://viagra.medical-dictionary-search-engines.com/. For more information about Viagra, please visit http://viagra.com/consumer/aboutViagra/index.asp

About the website above:

Is built for new generation of eCommerce which committed to simplifying the life of millions internet users in a new way online shopping. The site and the supporting staff are dedicated to make eCommerce and online shopping fun, reliable, and easy. The site is easy to use and help merchants to minimize setup and maintenance, while maximizing return on investment. For more information please feel free to contact us.

Disclaimer:

Data and information provided by the above website(s), contents, materials, goods, and or services are for informational purposes only. The creator, webmaster, and the related staff of the website(s) shall not be liable for any errors in the content. For detail please visit the disclaimer section of the website(s).




















VocusВ©Copyright 1997-2010, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.







Carie Boyd’s Compounding Pharmacy Retracts Statements Made in “Rapid-Dissolve Viagra” Press Release

 

Carie Boyd’s Compounding Pharmacy Retracts Statements Made in “Rapid-Dissolve Viagra” Press Release











Hurst, TX (PRWEB) April 22, 2010

Carie Boyd’s Compounding Pharmacy wishes to retract all of the statements about Professional Compounding Centers of America (PCCA) and Viagra that appeared in a news release on April 15, 2010 entitled “Rapid-Dissolve ViagraВ® Now Available from Carie Boyd’s Compounding Pharmacy.” The information included in the press release was distributed without the knowledge or consent of PCCA or Pfizer (the pharmaceutical company that manufactures and distributes ViagraВ®) and Carie Boyd’s Compounding Pharmacy encourages anyone who has read the previous release to disregard all references to both PCCA and ViagraВ®. Carie Boyd’s Compounding Pharmacy values its continued professional relationships with PCCA and Pfizer and sincerely apologizes for any confusion or distress the release may have caused.В В В В 

About Carie Boyd’s Compounding Pharmacy

Carie Boyd’s Compounding Pharmacy provides customers in the Dallas/Fort Worth Metroplex with customized compounded prescription medications and high-quality nutritional supplements that meet their specific health and wellness needs. Find out more about Carie Boyd’s Compounding Pharmacy at http://www.carieboyd.com.

###









Attachments






















VocusВ©Copyright 1997-2010, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.







Count on Konica Minolta for Award-Winning Technologies at GRAPH EXPO

 


bizhub PRESS C8000


Ramsey, N.J. (Vocus) September 27, 2010

Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta), a leading provider of advanced imaging and networking technologies for the desktop to the print shop, today announced the company will highlight the newest and most innovative production print technologies at 2010 GRAPH EXPO in Chicago, Ill. on October 3-6, 2010.

Of special note to media and analyst attendees, Konica Minolta will host a press conference at 11a CT on Monday, October 4, at McCormick Place South to discuss the following technologies – all of which will be featured at the Konica Minolta Booth #2244 throughout the show:

bizhub® PRESS C8000 – The flagship of Konica Minolta’s next-generation line of color digital presses, this new product combines stable, high-resolution output with uncompromised full-color quality at fast speeds of 80 pages per minute (ppm). The bizhub PRESS C8000 has already been deemed an award-winner for its innovative technologies including a “Best of Show” Award at the 2010 ON DEMAND Conference and Exposition in the Color Digital Printing Equipment category.

bizhub PRO C65hc – This color digital press incorporates innovative toner technology, enabling it to produce an unprecedented spectrum of color, and cater to graphics professionals and print shops that require higher-quality output.

bizhub PRO 1200 – This 120 monochrome ppm system was designed exclusively for production print professionals, and features in-line finishing options and an energy-saving design.

New Product Introductions – Konica Minolta will unveil a new series of color digital presses designed to strengthen our market-leading position in the production print arena and enhance print professionals’ return on investment (ROI).

Printgroove – In light production printing, CRD and small- to mid-sized print shop applications, Printgroove® is the key to greater output power and increased satisfaction for customers and corporate clients. It can accept input in any format, including text, graphics, photos, even presentations and multimedia. And it can be configured to fit your workflow like a glove, handling rising traffic volume and accommodating as many printing steps and stations as your business processes demand.

Third Party Offerings – Konica Minolta will showcase a number of application solutions developed with Third Party Partners, and designed to enhance customers’ production workflow. Among the companies to be featured in the Konica Minolta Booth are CREO, EFI, Objectif Lune, and RSA.

Konica Minolta’s Business Development Program – This offering provides Konica Minolta customers with access to powerful educational tools including white papers, videos, webinars, and ROI calculators that will help them develop innovative digital business strategies, launch new digital applications, and learn from customer success stories.

Latest Spectrodensitometer Technology – When it comes to color, light and shape measurement – the world looks to Konica Minolta. Our colleagues at Konica Minolta Sensing Americas, the worldwide leader in the industrial measurement of color, light and shape, will unveil its new FD-Series Spectrodensitometers and COLIBRI® color matching software to the digital imaging market.

“Our customers want strategic, cutting-edge partners that help them successfully navigate through competitive graphic communications markets,” said Kevin Kern, Senior Vice President, Marketing, Konica Minolta Business Solutions U.S.A., Inc. “They are able to count on Konica Minolta to provide them with the right technology, the right workflow, and the right business development tools to be successful. We invite all attendees to stop by the Konica Minolta Booth at GRAPH EXPO and learn how you too can count on Konica Minolta for all of your digital printing needs.”

Witness Konica Minolta in action at GRAPH EXPO 2010 (October 3 through October 6) at McCormick Place South in Chicago, Illinois. To schedule a personal tour of the Konica Minolta Booth (#2244), reserve a spot at the Konica Minolta Press Conference, and/or an executive interview, please contact Rachel Reed at Rachel(dot)Reed(at)kmbs(dot)konicaminolta(dot)us.

About Konica Minolta

Konica Minolta Business Solutions U.S.A., Inc. is a leader in advanced imaging and networking technologies for the desktop to the print shop. In 2009, Konica Minolta was named Supplier of the Year by both the Allegra Network and the National Association of Quick Printers (NAQP), as well as received the Sales Support Award from Mail Boxes Etc., Inc. Follow Konica Minolta on Facebook, YouTube, and Twitter.

Konica Minolta Contact

Rachel Reed

Konica Minolta Business Solutions U.S.A., Inc.

Konica Minolta is a registered trademark of Konica Minolta Holdings, Inc. bizhub and Printgroove are registered trademarks of Konica Minolta Business Technologies, Inc. All other trademarks mentioned in this document are the property of their respective owners.

###